Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly

European Journal of Internal Medicine

Volumn 22, Issue 2, 2011, Pages 205-210

  Pasina, L ^a   Nobili, A ^a   Tettamanti, M ^a   Salerno, F ^b   Corrao, S ^c   Marengoni, A ^d   Iorio, A ^e   Marcucci, M ^e   Mannucci, P M ^f  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Appropriateness; Elderly; Proton pump inhibitors

Indexed keywords

PROTON PUMP INHIBITOR;

AGED; ARTICLE; COHORT ANALYSIS; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRESCRIPTION; PREVALENCE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FEMALE; GASTROESOPHAGEAL REFLUX; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; PEPTIC ULCER; PREVALENCE;

EID: 79952699499     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.11.009     Document Type: Article

References (45)

1. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ 2008;336:2-3.
2. AIFA. L'uso dei farmaci in Italia. Rapporto nazionale anno 2008. http://www.agenziafarmaco.it/allegati/rapporto-osmed-2008.pdf (accessed on october 2009).
3. Walker NM, McDonald. An evaluation of the use of proton pump inhibitors. Pharm World Sci 2001;23:116-7.
4. Batuwitage BT, Kingham JGC, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 2007;83:66-8.
5. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther 2000;25:333-40. (Pubitemid 32002877)
6. Lanza FL, Chan FK, Quigley EM. Practice Parameters Commitee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009;104:728-38.
7. AIFA. Le Note AIFA per l'uso appropriato dei farmaci. http://www.agenziafarmaco.it./wscs-render-attachment-by-id/111.90291. 1168607405163575e.pdf?id=111.88204.1168596628882 2008.
8. George CJ, Korc B, Ross JS. Appropriate proton pump inhibitor use among older adults: a retrospective chart review. Am J Geriatr Pharmacother 2008;6:249-54.
9. Ntaios G, Chatzinikolaou A, Kaiafa G. Evaluation of use of proton pump inhibitors in Greece. Eur J Intern Med 2009;20:171-3.
10. Ryder SD, O'Reilly S, Miller RJ, Ross J, Jacyna MR, Levi AJ. Long term acid suppressing treatment in general practice. BMJ 1994;308:827-30.
11. Hollingworth S, Duncan EL, Martin JH. Marked increase in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf Oct 2010;19(10):1019-24.
12. Howden CW, henning JM, Huang B. Management of heartburn in a large, randomized, community based study: comparison of fuor therapeutic strategies. Am J Gastroenterol 2001;96:1704-10.
13. Caro JJ, Salas M, Ward A. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton pump inhibitors lansoprazole, rabeprazole and pantoprazole compared with omeprazole, ranitidine and placebo: evidence from randomize clinical trials. Clin Ther 2001;23:998-1017. (Pubitemid 32709623)
14. Wu CY, Chan FK, Wu MS, Kuo KN, Wang CB, Tsao CR, et al. Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel. Gastroenterology 2010;139(4):1165-71.
15. Woodhouse KW, O'Mahony MS. Frailty and aging. Age Aging 1997;26:245-6.
16. Gurwitz JH, Rochon P, for the Food and Drug Administration (US). Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med 2002;162:1670-2.
17. Simonson W, Feinberg JL. Medication-related problems in the elderly: defining the issues and identifying solutions. Drugs Aging 2005;22:559-69. (Pubitemid 41214549)
18. Laheij RJ, Sturkenboom MC, Hassing RJ. Risk of community-acquired pneumonia and use of gastric acidsuppressive drugs. JAMA 2004;292:1955-60. (Pubitemid 39411203)
19. Gulmez SE, Holm A, Frederiksen H. Use of proton pump inhibitors and the risk of community-acquired pneumonia. A population-based case-control study. Arch Intern Med 2007;167:950-5.
20. Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med 2008;149:391-8.
21. Herzig SJ, Howell MD, Ngo LH. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009;301(20):2120-8.
22. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community acquired Clostridium difficile-associated disease. JAMA 2005;294:2989-95. (Pubitemid 41817660)
23. Choudhry MN, Soran H, Ziglam HM. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease. QIM 2008;101:445-8. (Pubitemid 351791527)
24. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 2010;170(9):772-8.
25. Bhatt DL. COGENT: A prospective, randomized, placebo-controlled trial of omeprazole in patients receiving aspirin and clopidogrel. Presented at: Transcatheter Cardiovascular Therapeutics; September 24, 2009; San Francisco, Calif.
26. Ho PM, Maddox TM, Wang L. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009;301(9):937-44.
27. Juurlink DN, Gomes T, Ko DT. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009;180(7).
28. Juurlink DN. Proton pump inhibitors and clopidogrel putting the interaction in perspective. Circulation 2009;120:2310-2.
29. Rassen JA, Choudhry NK, Avorn J. Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation 2009;120:2322-9.
30. Stockl KM, Le L, Zakharyan A, Harada AS, Solow BK, Addiego JE, Ramsey S. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Arch Intern Med 2010;170(8):704-10.
31. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006;296:2947-53. (Pubitemid 46021498)
32. Targownik LE, Lix LM, Metge CJ. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 2008;179:319-26.
33. Gray SL, LaCroix AZ, Larson J, Robbins J, Cauley JA, Manson JE, et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med 2010;170(9):765-71.
34. Fernández-Fernández FJ, Sesma P. Gastric cancer. Lancet 2009;374(9701):1594 7.
35. Bell JS, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkälä KH. Use of proton pump inhibitors and mortality among institutionalized older people. Arch Intern Med Sep 27 2010;170(17):1604-5.
36. World Health Organization. International Classification of Diseases, Injuries, and Causes of Death. . Ninth Revision (ICD-9).Geneva: World Health Organization; 1987.
37. World Health Organization. Guidelines for ATC Classification. Sweden, WHO Collaborating Centre for Drug Statistics Methodology, Norway and Nordic Councils on Medicines, 1990.
38. Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, et al. NSAID-Associated Gastric Ulcer Prevention Study Group. Ulcer prevention in long-term users of Nonsteroidal Antinflammatory Drugs. Arch Intern Med 2002;162:169-75.
39. Derry S, Loke YK. Risk of gastrointestinal hemorrhage with long term use of aspirin: meta-analysis. BMJ 2000;321:1183-7.
40. Walker NM, McDonald J. An evaluation of the use of proton pump inhibitors. Pharm World Sci 2001;23(3):116-7. (Pubitemid 32607023)
41. Sebastian SS, Kernan N, Qasim A. Appropriateness of gastric antisecretory therapy in hospital practice. Ir J Med Sci 2003;172(3):115-7. (Pubitemid 37498185)
42. Parente F, Cucino C, Gallus S. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther 2003;17:1503-6. (Pubitemid 36833294)
43. Pillans PI, Kubler PA, Radford JM, Overland V. Concordance between use of proton pump inhibitors and prescribing guidelines. Med J Aust 2000;172:16-8. (Pubitemid 30043106)
44. De Burgas Lunar C, Novo del Castillo S, Llorente Díaz E. Study of prescription-indication of proton pump inhibitors. Rev Clín Esp Jun 2006;206(6):266-70. (Pubitemid 44102789)
45. Asensio AN, Barrientos RR, Castro PZ. Use of acid-suppressive medications in hospitalized patients. Ann Med Intern Nov 2002;19(11):557-60.